Objective: To study the in¯uence of supplementation with antioxidants on factors, which might increase the risk of coronary heart disease (CHD) in Iranians. Design: Twenty-one male volunteers enter the prospective, single-blind, randomized study. Setting: The supplementation was conducted at the Cardiovascular Center, University of Tehran, the biochemical analysis were carried out in the University of Graz. Subjects: Twenty-one male medical students were recruited by advertisement. Five subjects were dropped out due to lack of the compliance. Methods: One group of Iranians received 30 mg/d b-carotene and placebo for a-tocopherol; the other received b-carotene plus 400 IU a-tocopherol for ten weeks. Concentrations of antioxidants in plasma and low density lipoproteins (LDL), plasma lipid pro®le, autoantibody against oxidized LDL (oLAb) and malondialdehyde (MDA) concentrations in plasma were measured. Oxidative resistance of LDL was estimated using conjugated diene assay. Results: Iranians had a signi®cantly lower plasma levels of total cholesterol (P`0.002), LDL-cholesterol (P`0.01) and high density lipoprotein-cholesterol (P`0.002), compared to healthy Austrian subjects (n 13). Although the baseline concentrations of a-tocopherol and b-carotene were comparable with Austrians, lycopene, canthaxanthin and lutein were signi®cantly higher in Iranians (P`0.03±0.001). In vitro oxidative resistance of LDL, measured as lag-time, was slightly higher (P`0.01) in Iranians comparing with Austrians. Plasma MDA and oLAb concentrations were signi®cantly higher in Iranians (P`0.001). Both dietary supplementations reduced plasma MDA concentrations (P`0.001±0.001). A key ®nding was that a supplement combined with atocopherol caused also a signi®cant increase of oLAb concentration (P b 0.01) as well as the signi®cant increase of lag-time (P b 0.005). Conclusions: This study shows that high plasma MDA level of Iranians can be decreased by b-carotene supplementation with or without a-tocopherol. However, a-tocopherol is a more powerful antioxidant, which can increase the resistance of LDL to oxidation, reduce the MDA concentrations in plasma and increase autoantibodies to oLDL.